Hongnan N. Mo

Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Overall Survival With Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer: A Single-Center Pooled Analysis.

Overall Survival With Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer: A Single-Center Pooled Analysis.

Journal: Thoracic cancer

Published: April 12, 2026

Sleep Disturbance, Treatment-Related Adverse Events, and Psychological Distress in Breast Cancer Patients: A Prospective Cohort Study.

Sleep Disturbance, Treatment-Related Adverse Events, and Psychological Distress in Breast Cancer Patients: A Prospective Cohort Study.

Journal: Patient preference and adherence

Published: March 11, 2026

Distinct immune microenvironment in HER2-low triple-negative breast cancer underlies inferior response to immunotherapy.

Distinct immune microenvironment in HER2-low triple-negative breast cancer underlies inferior response to immunotherapy.

Journal: NPJ precision oncology

Published: January 23, 2026

Applications of Metabolomics to the Clinical Management of Breast Cancer: New Perspectives for Diagnosis, Treatment and Prognosis.

Applications of Metabolomics to the Clinical Management of Breast Cancer: New Perspectives for Diagnosis, Treatment and Prognosis.

Journal: International journal of molecular sciences

Published: January 23, 2026

Prognostic value of Ki-67 index in malignant phyllodes tumor of the breast: a multi-center real-world study.

Prognostic value of Ki-67 index in malignant phyllodes tumor of the breast: a multi-center real-world study.

Journal: Breast cancer research : BCR

Published: October 27, 2025

Efficacy and safety of PARP inhibitors in metastatic breast cancer patients with homologous recombination repair pathway gene mutations: a retrospective multicenter real-world study.

Efficacy and safety of PARP inhibitors in metastatic breast cancer patients with homologous recombination repair pathway gene mutations: a retrospective multicenter real-world study.

Journal: Therapeutic advances in medical oncology

Published: July 22, 2025

Paclitaxel drives TREM2+ macrophage expansion underlying its inferior therapeutic efficacy compared to Nab-paclitaxel.

Paclitaxel drives TREM2+ macrophage expansion underlying its inferior therapeutic efficacy compared to Nab-paclitaxel.

Journal: Nature communications

Published: June 20, 2025

STS2 deficiency revives CD8+T cells from exhaustion and augments checkpoint blockade efficacy in cancer immunotherapy.

STS2 deficiency revives CD8+T cells from exhaustion and augments checkpoint blockade efficacy in cancer immunotherapy.

Journal: Journal for immunotherapy of cancer

Published: May 29, 2025

Machine learning survival model for personalised prevention of catheter-related thrombosis in tumour patients.

Machine learning survival model for personalised prevention of catheter-related thrombosis in tumour patients.

Journal: Communications medicine

Published: May 14, 2025

Dalpiciclib plus endocrine therapy in women with HR+/HER2- advanced breast cancer and visceral crisis: a multicenter, nonrandomized, phase 2 DARVIN trial.

Dalpiciclib plus endocrine therapy in women with HR+/HER2- advanced breast cancer and visceral crisis: a multicenter, nonrandomized, phase 2 DARVIN trial.

Journal: Nature cancer

Published: April 25, 2025

Metronomic Chemotherapy in Breast Cancer: Unleashing the Potential of Combination Regimens.

Metronomic Chemotherapy in Breast Cancer: Unleashing the Potential of Combination Regimens.

Journal: Cancer innovation

Published: February 25, 2025

Systemic immune characteristics predicting toxicity to immune checkpoint inhibitors in patients with advanced breast cancer.

Systemic immune characteristics predicting toxicity to immune checkpoint inhibitors in patients with advanced breast cancer.

Journal: Journal of autoimmunity

Published: January 30, 2025

Showing 1-12 of 64

Last Updated: 09/26/2026